Back to search
FDAFDA · Food and drugs·Recall number Z-0753-2024

Calibration Serum Level 3 - IVD For use as a Calibrator in clinical chemistry assays Catalog Number: CAL2351

Published January 24, 2024 · Recall initiated: November 20, 2023

Summary

FDA records medical device Class II recall Z-0753-2024, published January 24, 2024 and initiated November 20, 2023. Recalling firm: Randox Laboratories Ltd.; Status: Ongoing; Reported quantity: 108 kits; Lot: GTIN: 05055273200966 Lot/Batch No: 1214UE Exp. Date: 28 Nov 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Target for Alkaline Phosphatase (ALP) for the AMP optimized to IFCC 37®C method has been mis-assigned for the RX Series instruments by approximately 10% on Quality Control and patient samples

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories Ltd.
Distributor
US Nationwide including Puerto Rico.
Lot
GTIN: 05055273200966 Lot/Batch No: 1214UE Exp. Date: 28 Nov 2023
Risk classification
Class II
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was Calibration Serum Level 3 - IVD For use as a Calibrator in clinical chemistry assays Catalog Number: CAL2351 recalled?

Yes. FDA published recall Z-0753-2024 on January 24, 2024. Reported hazard: Target for Alkaline Phosphatase (ALP) for the AMP optimized to IFCC 37®C method has been mis-assigned for the RX Series instruments by approximately 10% on Quality Control and patient samples

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail